Featured Journal Content
Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 02 March 2022
[Full scale view available at title link above]
[Updated on 02 March 2022]
COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
Featured Journal Content
COVID Vaccines/Therapeutics – Developer/Manufacturer Announcements
[Selected press releases/announcements from organizations from WHO EUL/PQ listing above and other organizations]
AstraZeneca
Press Releases
Evusheld long-acting antibody combination recommended for approval in the EU for the pre-exposure prophylaxis (prevention) of COVID-19
24 March 2022
Bharat Biotech
Press Releases – No new digest announcements identified
BioCubaFarma – Cuba
Últimas Noticias – Website not leading at inquiry
Biontech
Press Releases – No new digest announcements identified
CanSinoBIO
News – Website not responding at inquiry
Clover Biopharmaceuticals – China
News – No new digest announcements identified
Curevac [Bayer Ag – Germany]
News – No new digest announcements identified
Gamaleya National Center
Latest News and Events – See Russia below.
IMBCAMS, China
Home – Website not responding at inquiry
Janssen/JNJ
Press Releases
Mar 24, 2022 United States
U.S. FDA Approves Streamlined Process for Initiating HIV Therapy with CABENUVA (cabotegravir and rilpivirine), the First and Only Complete Long-Acting Injectable HIV Treatment
Moderna
Press Releases
March 24, 2022
Moderna Announces Clinical and Program Updates at 3rd Annual Vaccines Day
COVID-19 vaccine Phase 2/3 study in children 6 months to under 6 years has successfully met its primary endpoint with robust neutralizing antibody titers similar to adults. Moderna is moving forward with global regulatory submissions for mRNA-1273 for primary vaccination of children 6 months to under 6 years of age.
Moderna has initiated a submission to the FDA for emergency use authorization of mRNA-1273 in children 6 to under 12 years of age; mRNA-1273 is approved for use in this age group in Europe, Canada, and Australia.
In an interim analysis of a Phase 2 study of influenza vaccine candidate mRNA-1010, no significant safety concerns were identified, and the immunogenicity data is consistent with a potential for superiority to standard dose vaccine for influenza A strains.
Moderna is advancing vaccine candidates against five viruses that cause latent infections, three of which are in clinical trials. In a Phase 2 study, the CMV vaccine (mRNA-1647) was observed to be generally well tolerated and interim data demonstrates strong immunogenicity.
Moderna announces an increase in signed Advance Purchase Agreements for 2022 from $19 billion announced on February 24, 2022, to $21 billion.
March 23, 2022
Moderna Finalizes Strategic Partnership with Australian Government
On-shore manufacturing facility based in Melbourne, Australia, expected to produce up to 100 million mRNA respiratory vaccine doses annually
March 23, 2022
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Novavax
Press Releases
Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine
Mar 25, 2022
Pfizer
Recent Press Releases
03.24.2022
Pfizer Granted FDA Breakthrough Therapy Designation for Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV in Older Adults
03.22.2022
Pfizer to Supply UNICEF up to 4 Million Treatment Courses of Novel COVID-19 Oral Treatment for Low- and Middle-Income Countries
Treatment courses will be available for supply to 95 low- and middle-income countries that account for approximately 53% of the world’s population beginning in April 2022
Agreement is part of Pfizer’s comprehensive strategy to work toward worldwide equitable access of COVID-19 oral treatment
Sanofi Pasteur
Press Releases – No new digest announcements identified
Serum Institute of India
NEWS & ANNOUNCEMENTS – No new digest announcements identified
Shifa Pharmed [Iran]
http://shafapharmed.com/
No news page identified.
Sinopharm/WIBPBIBP
News – No new digest announcements identified
Sinovac
Press Releases
Three doses of SINOVAC COVID-19 vaccine well prevent the worst outcomes during HK Omicron wave
2022/03/23
A study of University of Hong Kong revealed that three shots of CoronaVac offered appromixtely 98% protection against death or severe illness in those over 60 years old, underscoring the importance of boosters for those who have received that Covid-19 shot…
The BRICS Vaccine R&D Center Launched SINOVAC Actively Responds to Common Initiatives
2022/03/23
In order to implement the consensus of the BRICS leaders’ meeting on the early launch of the BRICS Vaccine R&D Center, on March 22, 2022, the Chinese Ministry of Science and Technology held an online launch ceremony of the BRICS Vaccine R&D Center and the Vaccine Cooperation Workshop. Leaders from science and technology and health departments of BRICS countries and representatives from each country’s center witnessed the launch of the center and discussed vaccine cooperation…
Vector State Research Centre of Viralogy and Biotechnology
Home – No new digest announcements identified
Zhifei Longcom, China
[Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.]
[No website identified]
::::::
GSK
Press releases for media – No new digest announcements identified
Merck
News releases
Merck Announces Retirement of Dr. Roy D. Baynes; Dr. Eliav Barr Appointed Head of Global Clinical Development and Chief Medical Officer
March 23, 2022
Novartis
News – No new digest announcements identified
SK Biosciences
Press releases – Website not responding at inquiry
Valneva
Press Releases – No new digest announcements identified
UNICEF COVID-19 Vaccine Market Dashboard :: Agreements Table Accessed 26 Mar 2022
Featured Journal Content
UNICEF COVID-19 Vaccine Market Dashboard :: Agreements Table Accessed 26 Mar 2022
An overview of information collected from publicly announced bilateral and multilateral supply agreements [no new agreements since 10/22/2021 reported]
COVID-19 Global Targets and Progress Tracker – IMF
Featured Journal Content
COVID-19 Global Targets and Progress Tracker – IMF
The COVID-19 Global Targets and Progress Tracker presents a consolidated view of the progress towards global COVID-19 targets, barriers in access to COVID-19 tools, and delivery of donor pledges.
The global targets presented in the Tracker are based on an alignment of the targets identified in the IMF Pandemic Proposal, ACT-A Strategic Plan & Budget, and the US-hosted Global C19 Summit, and as such have been reaffirmed by multilateral institutions and global leaders. We will continue to enhance the tracker as we improve our data collection efforts.
Global Dashboard on COVID-19 Vaccine Equity
Featured Journal Content
Global Dashboard on COVID-19 Vaccine Equity
The Dashboard is a joint initiative of UNDP, WHO and the University of Oxford with cooperation across the UN system, anchored in the SDG 3 Global Action Plan for Healthy Lives and Well-being for All.
Dashboard on Vaccine Equity [accessed 26 Mar 2022]: https://data.undp.org/vaccine-equity/
See also visualization on Vaccine Access and Vaccine Affordability
Global COVID-19 Access Tracker
The Race for Global COVID-19 Vaccine Equity
Featured Journal Content
Duke – Launch and Scale Speedometer
The Race for Global COVID-19 Vaccine Equity
A flurry of nearly 200 COVID-19 vaccine candidates are moving forward through the development and clinical trials processes at unprecedented speed; more than ten candidates are already in Phase 3 large-scale trials and several have received emergency or limited authorization. Our team has aggregated and analyzed publicly available data to track the flow of procurement and manufacturing and better understand global equity challenges. We developed a data framework of relevant variables and conducted desk research of publicly available information to identify COVID vaccine candidates and status, deals and ongoing negotiations for procurement and manufacturing, COVID burden by country, and allocation and distribution plans. We have also conducted interviews with public officials in key countries to better understand the context and challenges facing vaccine allocation and distribution
[accessed 24 July 2021]
See our COVID Vaccine Purchases research
See our COVID Vaccine Manufacturing research
See our COVID Vaccine Donations & Exports research
COVID-19 Data Explorer: Global Humanitarian Operations
Featured Journal Content
COVID Vaccines – OCHA:: HDX
COVID-19 Data Explorer: Global Humanitarian Operations
COVID-19 Vaccine Roll-out
26 Mar 2022 | COVAX (WHO,GAVI,CEPI), UNDESA, Press Reports | DATA
Global COVID-19 Figures: 476M total confirmed cases; 6.1M total confirmed deaths
Global vaccines administered: 11.1B
Number of Countries: 28
COVAX Allocations Round 4-9 (Number of Doses): 170M
COVAX Delivered (Number of Doses): 270M
Other Delivered (Number of Doses): 260M
Total Delivered (Number of Doses): 530M
Total Administered (Number of Doses): 380M
Multilateral Leaders Task Force on COVID-19 [IMF, World Bank Group, WHO, WTO]
Featured Journal Content
Multilateral Leaders Task Force on COVID-19 [IMF, World Bank Group, WHO, WTO]
https://data.covid19taskforce.com/data
A global effort to help developing countries access and deliver COVID-19 vaccines, testing, and therapeutics, as they work to end the pandemic and boost economic recovery.
The International Monetary Fund, World Bank Group, World Health Organization and World Trade Organization have joined forces to accelerate access to COVID-19 vaccines, therapeutics and diagnostics by leveraging multilateral finance and trade solutions, particularly in low- and middle-income countries.
Website accessed 26 Mar 2022: https://data.covid19taskforce.com/data The global view below is complemented by country-specific dashboards here.
Coronavirus (COVID-19) Vaccinations [Accessed 26 Mar 2022]
Featured Journal Content
Our World in Data
Coronavirus (COVID-19) Vaccinations [Accessed 26 Mar 2022]
64.2% of the world population has received at least one dose of a COVID-19 vaccine.
11.16 billion doses have been administered globally, and 15.63 million are now administered each day.
Only 14.4% of people in low-income countries have received at least one dose.
U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Featured Journal Content
U.S.: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
HHS
News
G7 Health Ministers condemn attacks on health facilities in Ukraine
March 23, 2022 | News Release
HHS Recognizes One-Year Anniversary of Health Center COVID-19 Vaccine Program to Advance Equity in Pandemic Response
March 21, 2022 | News Release
BARDA – U.S. Department of HHS [to 26 Mar 2022]
https://aspr.hhs.gov/newsroom/Pages/NewsRoomHome.aspx
News
No new digest content identified.
::::::
FDA
Press Announcements
March 21, 2022 – Coronavirus (COVID-19) Update: FDA to Hold Advisory Committee Meeting on COVID-19 Vaccines to Discuss Future Boosters
Vaccines and Related Biological Products Advisory Committee– FDA
https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologics/vaccines-and-related-biological-products-advisory-committee
Calendar
Vaccines and Related Biological Products Advisory Committee Meeting April 6, 2022 Announcement – 04/06/2022
The committee will meet in open session to discuss considerations for use of COVID-19 vaccine booster doses and the process for COVID-19 vaccine strain selection to address current and emerging variants.
::::::
White House [U.S.] [to 26 Mar 2022]
Briefing Room – Selected Major COVID Announcements
Press Briefing by White House COVID-19 Response Team and Public Health Officials
March 23, 2022 Press Briefings
U.S. Department of State [to 26 Mar 2022]
https://www.state.gov/coronavirus/releases/
Press Statement
No new digest content identified.
USAID [to 26 Mar 2022]
https://www.usaid.gov/news-information/press-releases/2021
Selected Press Releases, Statements, Announcements
News
The United States Announces More Than $195 Million in Additional Humanitarian Assistance for South Sudan
March 25, 2022
The United States, through the U.S. Agency for International Development (USAID) is providing more than $195 million in additional humanitarian assistance for the people of South Sudan, who continue to experience the devastating effects of violence, food insecurity, the COVID-19 pandemic, and successive years of widespread flooding. Approximately 8.9 million people, more than two-thirds of the country’s population, will require humanitarian assistance this year, an increase of 600,000 since 2021.
USAID Provides Nearly $64 Million in Emergency Food Assistance for Vulnerable People Affected by the Crisis in Lebanon
March 23, 2022
In response to growing food security needs in Lebanon, the United States, through the U.S. Agency for International Development (USAID) is providing nearly $64 million in additional humanitarian assistance to help feed vulnerable people in Lebanon. Lebanon is facing increased food insecurity amid the country’s ongoing economic crisis, as well as prolonged impacts of the COVID-19 pandemic, and the August 2020 Beirut port blast. This situation is exacerbated by Putin’s war against Ukraine due to Lebanon’s reliance on imported wheat, primarily from Ukraine. USAID remains concerned that increasing prices of staple foods and fuel in Lebanon will worsen food insecurity. The U.S. government is committed to providing much-needed assistance to the most vulnerable populations in Lebanon.
Administrator Samantha Power on Designation of Atrocities Against Rohingya as Genocide
March 21, 2022
Today, Secretary of State Antony J. Blinken announced that the United States has determined that the Burmese military committed genocide and crimes against humanity against the Rohingya people. All of us are grateful for the committed and forceful advocacy of Rohingya survivors of this genocide—survivors who have already demonstrated unimaginable resilience and bravery in the face of horror—as well as a range of organizations who have worked to document the Burmese military’s crimes.
Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Featured Journal Content
Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
European Medicines Agency
News & Press Releases
Press Releases
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 2022 (new)
CHMP, Last updated: 25/03/2022
News: EMA recommends authorisation of COVID-19 medicine Evusheld (new)- AstraZeneca
CHMP, Last updated: 24/03/2022
::::::
European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates [Selected]
News
Tuberculosis remains one of the deadliest infectious diseases worldwide, warns new report
Press release – 24 Mar 2022
According to the latest ECDC/WHO report on tuberculosis (TB) surveillance and monitoring in Europe, a sharp drop (24%) in reported tuberculosis cases between 2019 and 2020 was probably exacerbated by the COVID-19 pandemic, which hindered detection and reporting. Tuberculosis remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug resistant TB strains are still a major concern. In the fight against tuberculosis, urgent investment is critical, especially in the context of the ongoing pandemic
News
ECDC: On Air – podcast on European epidemiology. Episode 17 out now!
Podcast – 24 Mar 2022
News
Epidemiological update: West Nile virus transmission season in Europe, 2021
Epidemiological update – 24 Mar 2022
Data
Presentation: Tuberculosis situation in the EU/EEA, 2020
Presentation – 24 Mar 2022
::::::
Accessed 26 Mar 2022
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab
::::::
European Commission
https://ec.europa.eu/commission/presscorner/home/en
Latest [Selected]
Press release 25 March 2022
Stand Up for Ukraine: European Commission and Government of Canada team up with Global Citizen to mobilise support for refugees
Press release 24 March 2022
EU strengthens partnership with WHO to boost local manufacturing and access to vaccines, medicines and health technologies in Africa
The Commission and the World Health Organization (WHO) are strengthening their partnership to improve equitable access to safe, effective, and quality-assured vaccines, medicines and health technologies in Sub-Saharan Africa.
[See COVID above for detail]
Press release 23 March 2022
Ukraine: €3.4 billion REACT-EU pre-financing to Member States welcoming refugees fleeing Ukraine
To support Member States welcoming and accommodating refugees fleeing the war in Ukraine, the Commission has today proposed to increase by €3.4 billion the total pre-financing from the Recovery Assistance for Cohesion and the Territories of Europe (REACT-EU).
Africa: COVID-19 – Announcements/Regulatory Actions/Deployment
Featured Journal Content
Africa: COVID-19 – Announcements/Regulatory Actions/Deployment
Accessed 26 Mar 2022. Full scale, interactive dashboard available at:
https://africacdc.org/covid-19-vaccination/
Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Featured Journal Content
Russia: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Russia: Sputnik V – “the first registered COVID-19 vaccine”
https://sputnikvaccine.com/newsroom/pressreleases/
Press Releases
No new digest content identified.
India: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Featured Journal Content
India: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Ministry of Health and Family Welfare
https://www.mohfw.gov.in/
21.03.2022 Guidelines for Covid-19 Vaccination of Children Between 12-14 Years of Age
Government of India – Press Information Bureau
Latest Press Releases
COVID – 19 Vaccination Update – Day 435
:: India’s cumulative vaccination coverage crosses 183.16 Crore
:: More than 26 lakh Vaccine doses administered today till 7 pm
:: More than 1.20 Crore Vaccine Doses administered to 12-14 age group so far
Posted On: 26 MAR 2022 8:06PM by PIB Delhi
Indian Council for Medical Research (ICMR)
https://www.icmr.gov.in/media.html
Press Releases
No new digest content identified.
China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
Featured Journal Content
China: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment
[See China CDC below]
POLIO Public Health Emergency of International Concern (PHEIC)
Emergencies
POLIO
Public Health Emergency of International Concern (PHEIC)
https://polioeradication.org/polio-today/polio-now/this-week/
Polio this week as of 23 March 2022
:: Revised containment guidance (GAPIII) soon available for public consultation: On recommendation from the Containment Advisory Group (CAG), and through wide engagement of stakeholders, WHO’s Global Action Plan for Poliovirus Containment (GAPIII, 2015) has been revised. Following a period of critical review by the CAG, the document draft will be made available for public consultation 29 March – 1 May 2022. Revisions to the guidance have been made based on CAG recommendations, review of relevant biorisk management documents to determine alignment, scientific evidence and solicited stakeholder comments on various sections. WHO encourages feedback from containment stakeholders. Please check the GPEI website for information. For queries, please email: containment@who.int.
Summary of new WPV and cVDPV viruses this week (AFP cases and ES positives):
– Côte d’Ivoire: one cVDPV2 positive environmental sample
– Niger: two cVDPV2 cases
– Nigeria: two cVDPV2 cases
– Yemen: three cVDPV2 cases
::::::
::::::
Disease Outbreak News (DONs)
Latest WHO Disease Outbreak News (DONs), providing information on confirmed acute public health events or potential events of concern.
25 March 2022 | Yellow Fever – Kenya
24 March 2022 | Extensively drug-resistant Shigella sonnei infections – Europe
24 March 2022 | Lassa Fever – Togo
::::::
::::::
WHO/OCHA Emergencies
Health emergencies list – WHO
“The health emergencies list details the disease outbreaks, disasters and humanitarian crises where WHO plays an essential role in supporting countries to respond to and recover from emergencies with public health consequences.”
Afghanistan crisis [Last apparent update: 14 March 2022]
Crisis in Northern Ethiopia [Last apparent update: 1 June 2021]
Ebola outbreak, Democratic Republic of the Congo, 2021 [Last apparent update: 17 Aug 2021]
Ebola outbreak outbreak, N’Zerekore, Guinea, 2021 [Last apparent update: 17 Aug 2021]
Coronavirus disease (COVID-19) pandemic [See COVID above]
Ebola outbreak, Equateur Province, Democratic Republic of the Congo, 2020
[Last apparent update: 17 Aug 2021]
Ebola outbreak, North Kivu, Ituri, Democratic Republic of the Congo, 2018 – 2020
[Last apparent update: 17 Aug 2021]
Ebola outbreak, Democratic Republic of the Congo, 2018 [Last apparent update: 24 July 2018]
Yemen crisis [Last apparent update: 12 February 2021]
Syria crisis [Last apparent update: 18 June 2021]
Somalia crisis [Last apparent update: 24 March 2018]
Nigeria crisis [Last apparent update: 1 Oct 2021]
Ebola outbreak, Democratic Republic of the Congo, 2017 [Last apparent update: 17 Aug 2021]
Zika virus disease outbreak, 2015-2016 [Last apparent update: 24 Jan 2020]
Ebola outbreak: West Africa, 2014-2016 [Last apparent update: 17 Aug 2021]
Iraq crisis [Last apparent update: 9 Jan 2008]
South Sudan crisis [Last apparent update: 23 Sep 2020]
Avian influenza A (H7N9) virus outbreak [Last apparent update: 13 September 2021]
Middle East respiratory syndrome (MERS-CoV) outbreak [Last apparent update: 8 July 2019]
Influenza A (H1N1) virus, 2009-2010 pandemic [Last apparent update: 10 Aug 2010]
::::::
UN OCHA – Current Emergencies
Current Corporate Emergencies
Afghanistan
No new updates identified.
Northern Ethiopia
Ethiopia – Northern Ethiopia Humanitarian Update Situation Report, 25 March 2022
HIGHLIGHTS
The food distribution in Tigray has reached an all-time low since March 2021 as food stocks are almost depleted with only about 68,000 people assisted between 10 – 16 March.
To date, 221.8 MT of medical supplies have been airlifted to Tigray which represents only four per cent of the total medications required to meet health needs in Tigray.
Nearly 12,000 children in 22 schools in Wag Hemra Zone in Amhara benefited from feeding program and more than more than 9,300 students received exercise books during the week.
More than 10,000 people assisted with food in Zone 2 in Afar during the week, reaching 126,000 or 20 percent of the targeted population since last week of February in the region.
No amount of operational cash cleared to be transferred to Tigray since 10 March.
Ukraine
Ukraine: Humanitarian Impact Situation Report (As of 12:00 p.m. (EET) on 25 March 2022)
:: [Excerpt]
…Health situation and risks.
…COVID-19 vaccination and routine immunization campaigns have almost come to a halt across the country. Before 24 February, at least 50,000 people on average were being vaccinated against COVID-19 each day. Between 24 February and 15 March, however, only 175,000 people were vaccinated against the virus – around 40,790 fewer people on average being vaccinated daily. Between 23 February and 23 March, WHO reports that the seven-day average number of antigenrapid and polymerase chain reaction (PCR) COVID-19 tests fell by a staggering 88 and 96 per percent, respectively, suggesting considerable underreporting of COVID-19 cases and deaths. Over the same period, the number of beds available for COVID-19 patients decreased significantly as many were repurposed, with the largest decreases witnessed in Luhanska (east, 80 per cent), Volynska (north-west, 69 per cent) and Chernihivska (north, 56 per cent) oblasts…
::::::
::::::
WHO & Regional Offices [to 26 Mar 2022]
WHO & Regional Offices [to 26 Mar 2022]
https://www.who.int/news
News [Selected]
25 March 2022
News release
WHO establishes the Global Centre for Traditional Medicine in India
24 March 2022
Departmental news
First case of HIV cure in a woman after stem cell transplantation reported at CROI-2022
21 March 2022
Departmental news
WHO releases clinical management guidelines for influenza
21 March 2022
Departmental news
Expanding the network: Togo gains National Influenza Centre
21 March 2022
Departmental news
“First time” achievements in pandemic influenza preparedness in two regions with high humanitarian and public health vulnerabilities, 2014-2021
21 March 2022
Departmental news
Insights to inform influenza health worker vaccination programmes
21 March 2022
News release
On World TB day WHO calls for increased investments into TB services and research
21 March 2022
Departmental news
Several Covid-19 vaccine specific recommendations updated
[See COVID above for detail]
21 March 2022
Departmental news
One Health is critical to addressing zoonotic public health threats and environmental issues
::::::
WHO Director General Speeches [selected]
https://www.who.int/director-general/speeches
Selected
24 March 2022
Speech
WHO Director-General’s Keynote address at the World TB Day Online Talk Show – 24 March 2022
23 March 2022
Speech
WHO Director-General’s opening remarks at the Quarterly Briefing for Member States on Preventing and Responding to Sexual Exploitation, Abuse and Harassment – 23 March 2022
23 March 2022
Speech
WHO Director-General’s opening remarks at the WHO press conference – 23 March 2022
21 March 2022
Speech
WHO Director-General’s opening remarks at the Guinea Worm Ministerial Summit – 21 March 2022
::::::
WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region
:: African countries scale back on COVID-19 measures 24 March 2022
:: Beating the resistance: tuberculosis treatment switch in Zimbabwe 24 March 2022
:: Low funding, COVID-19 curtail tuberculosis fight in Africa 24 March 2022
WHO Region of the Americas PAHO
:: 23 Mar 2022 On World Tuberculosis Day, PAHO calls for increased investments in TB services
TB deaths in the Americas increased by an estimated 3,000 in 2020 compared to 2019 due to the COVID-19 pandemic. Around 18,300 children live with the disease in the region, with limited access to diagnosis and treatment Washington, D.C., March 23, 2022 (WHO)- On World Tuberculosis Day, the Pan American Health Organization (PAHO) calls for urgent…
WHO South-East Asia Region SEARO
:: 24 March 2022 Statement World Tuberculosis Day: Invest to End TB. Save Lives
WHO European Region EURO
:: European Technical Advisory Group updates recommendations for prioritization and use of COVID-19 vaccines 25-03-2022
:: Slovenia: working with civil society to better support and integrate refugees and migrants during the pandemic 24-03-2022
:: WHO/Europe advisory group issues revised recommendations on schooling during COVID-19 24-03-2022
:: The Republic of Moldova continues tuberculosis treatment for Ukrainian refugees 24-03-2022
:: Tuberculosis remains one of the deadliest infectious diseases worldwide, warns new report 24-03-2022
WHO Eastern Mediterranean Region EMRO
:: 24 March 2022 Statement World Tuberculosis Day: Invest to End TB. Save Lives
WHO Western Pacific Region
:: Pacific Health Ministers commit to strengthening health systems to meet current and future health challenges 24 March 2022 Joint News Release
::::::
WHO Events
https://www.who.int/news-room/events/1
[Selected]
Towards the International Migration Review Forum: Information session on the health of migrants
28 March 2022 15:00 – 16:30 CET
16th meeting of the Vector Control Advisory Group (VCAG)
28 – 30 March 2022
Strategic Advisory Group of Experts on Immunization (SAGE) – April 2022
4 – 7 April 2022
::::::
New WHO Publications
https://www.who.int/publications/i
Selected Titles
25 March 2022
Report of the 7th virtual end TB strategy summit for the highest TB burden countries and countries on the WHO global watchlist, 16–17 November 2021
Overview
The 7th End TB summit of the highest TB burden countries and countries on the WHO Global TB Watchlist took place virtually from 16 to 17 November 2021 (3.5 hours per day). The overall objective of this summit was to facilitate discussions and an exchange of strategic information between National TB Programmes (NTPs), representatives of the WHO Civil Society Task Force, and partners on new ways of working to mitigate and reverse the COVID-19 impact on
TB and reinvigorate the global response to TB. Specific meeting objectives were as follows:
1. to reflect on key challenges and opportunities posted by the ongoing COVID-19 pandemic for NTPs, affected people and vulnerable populations;
2. to consider opportunities for strengthening quality TB case finding and prevention given innovations during the COVID-19 pandemic;
3. to share updates on the latest global situation for TB and exchange strategic information.
This report summarizes the sessions of the summit and provides links to background slides shared by speakers from the country, regional and global level. All slides are featured in the WHO End TB Forum.
24 March 2022
Emergency in Ukraine: external situation report #4, published 24 March 2022: reporting period: 17–23…
24 March 2022
mhGAP Humanitarian Intervention Guide (mhGAP-HIG) training of health-care providers
21 March 2022
Guidelines for drinking-water quality: Fourth edition incorporating the first and second addenda
21 March 2022
WHO consolidated guidelines on tuberculosis Module 5: Management of tuberculosis in children and adolescents
21 March 2022
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
20 March 2022
Tool to assess impact of human resources for health investments on HIV, TB and malaria services and health…
20 March 2022
Tool to assess impact of human resources for health investments on HIV, TB and malaria services and health…
20 March 2022
Tool to assess impact of human resources for health investments on HIV, TB and malaria services and health…
ACIP Meetings
ACIP Meetings
Next meeting scheduled for June 22-23, 2022
MMWR Weekly: Current Volume (71)
MMWR Weekly: Current Volume (71)
March 25, 2022 / No. 12
PDF of this issuepdf icon
Tuberculosis — United States, 2021
Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic — 41 PEPFAR-Supported Countries, 2020
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
Coronavirus Disease 2019 (COVID-19)- CDC
Coronavirus Disease 2019 (COVID-19)– CDC
Approximately 25 announcements/reports/data summaries.
:: 3/25/22 EARLY RELEASE: Use of At-Home COVID-19 Tests — United States, August 23, 2021–March 12, 2022
:: 3/25/22 Overall US COVID-19 Vaccine Distribution and Administration Update as of Fri, 25 Mar 2022 06:00:00 EST
…
Africa CDC [to 26 Mar 2022]
Africa CDC [to 26 Mar 2022]
http://www.africacdc.org/
News
Outbreak Brief 114: Coronavirus Disease 2019 (COVID-19) Pandemic
Date of Issue: 14 March 2022
… As of 6 p.m. East African Time (EAT) 21 March 2022, a total of 11,301,084 COVID-19 cases and 250,646 deaths (CFR: 2.2%) have been reported by the 55 African Union (AU) Member States (MS). This represents 2.4% of all cases and 4.1% of all deaths reported globally. Thirty-five (64%) AU MS are reporting CFRs higher than the global CFR. Since the detection of COVID-19 on the African continent in February 2020, 53 (96%) AU MS have experienced three COVID-19 waves, 47 (72%) countries have experienced four waves and nine countries have experienced five waves. One country (Mauritius) is currently experiencing a sixth wave… Despite a test positivity rate of 11.1%, the daily reported number of new cases across the continent is on a downward trend. In the past week, more than 572 thousand new tests were conducted, which is a 32% decrease in the number of tests conducted in week 11 compared to the previous week…
China CDC http://www.chinacdc.cn/en/
China CDC http://www.chinacdc.cn/en/
National Health Commission of the People’s Republic of China [to 26 Mar 2022]
News
Chinese mainland reports 1,301 new local COVID-19 cases
2022-03-25
The Chinese mainland on Thursday reported 1,301 locally transmitted COVID-19 cases, down from 2,010 on Wednesday, the National Health Commission said Friday.
National Medical Products Administration – PRC [to 26 Mar 2022]
News
Chinese mainland reports 1,301 new local COVID-19 cases
2022-03-25
The Chinese mainland on Thursday reported 1,301 locally transmitted COVID-19 cases, down from 2,010 on Wednesday, the National Health Commission said Friday.
CCDC Weekly Reports: Current Volume (4)
2022-03-25 / No. 12 CHINA PIN ISSUE
View PDF of this issue
- Foreword: Performing Laboratory Network Surveillance to Monitor the Emergence and Spread of Infectious Diseases
- Healthy China: Chinese Pathogen Identification Net: A Laboratory Network for Surveillance and Response of Bacterial Infectious Diseases
- Vital Surveillances: Phylogenetic Analysis of Serogroup O5 Vibrio cholerae that Caused Successive Cholera Outbreaks — Guangdong Province, China, 2020–2021
- Vital Surveillances: Trans-Regional and Cross-Host Spread of mcr-Carrying Plasmids Revealed by Complete Plasmid Sequences — 44 Countries, 1998−2020
- Outbreak Reports: Anaplasma bovis Infection in Fever and Thrombocytopenia Patients — Anhui Province, China, 2021
- Outbreak Reports: Extensively Drug-Resistant (XDR) Salmonella Typhi Outbreak by Waterborne Infection — Beijing Municipality, China, January–February 2022
Organizational Announcements
Editor’s Note:
Careful readers will note that the number and range of organizations now monitored in our Announcements section below has grown as the impacts of the pandemic have spread across global economies, supply chains and programmatic activity of multilateral agencies and INGOs.
Airfinity [to 26 Mar 2022]
https://www.airfinity.com/insights
INSIGHTS & COMPANY NEWS
No new digest content identified.
Paul G. Allen Frontiers Group [to 26 Mar 2022]
https://alleninstitute.org/news-press/
News
No new digest content identified.
BMGF – Gates Foundation [to 26 Mar 2022]
https://www.gatesfoundation.org/ideas/media-center
Press Releases and Statements
No new digest content identified.
Bill & Melinda Gates Medical Research Institute [to 26 Mar 2022]
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.
News
No new digest content identified.
Center for Vaccine Ethics and Policy – GE2P2 Global Foundation [to 26 Mar 2022]
https://centerforvaccineethicsandpolicy.net/
:: Informed Consent: A Monthly Review – March 2022is now posted here
:: Past weekly editions and posting of all segments of Vaccines and Global Health: The Week in Review are available here.
CEPI – Coalition for Epidemic Preparedness Innovations [to 26 Mar 2022]
Latest News
No new digest content identified.
DARPA – Defense Advanced Research Projects Agency [U.S.] [to 26 Mar 2022
News
No new digest content identified.
Duke Global Health Innovation Center [to 26 Mar 2022]
No new digest content identified.
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
News
24 March 2022
24 March 2022
World TB Day 2022: EDCTP invests to End TB
On this year’s World TB Day, EDCTP joins the global health community in a call to urgently raise investments to achieve the commitments to end TB made by global leaders. Although funding towards TB research and development did not decrease as significantly as expected during the COVID-19 pandemic, it is still below half of the $2 billion annual financing target committed to by governments at the United Nations General Assembly High-Level Meeting on TB in 2018. In recognition of this chronic underfunding, EDCTP has made substantial investments in TB research and, together with our partners, recently launched the Global TB vaccine R&D roadmap and published several tools to accelerate TB vaccines R&D.
Emory Vaccine Center [to 26 Mar 2022]
http://www.vaccines.emory.edu/
Vaccine Center News
No new digest content identified.
European Vaccine Initiative [to 26 Mar 2022]
Latest News, Events
24 March 2022
Invest into new, effective TB vaccines to save lives!
Evidence Aid [to 26 Mar 2022]
Evidence Aid aims to save lives and livelihoods in disasters by providing decision-makers with the best available evidence and by championing its use.
Pharmacotherapy for posttraumatic stress disorder (PTSD) Added March 24, 2022
Fondation Merieux [to 26 Mar 2022]
http://www.fondation-merieux.org/
Project
March 22, 2022 – Antananarivo, Madagascar
On March 18, 2022, the stakeholders of the APRECIT project met in Madagascar and remotely for the project’s second steering committee for the improvement of the management of latent tuberculosis infection (LTI)…
News Releases
No new digest content identified.
https://www.ghitfund.org/newsroom/press
No new digest content identified.
https://www.theglobalfund.org/en/news/
News & Stories
25 March 2022
Global Fund Praises Germany’s Commitment to the ACT-Accelerator and the COVID-19 Response Mechanism
The Global Fund to Fight AIDS, Tuberculosis and Malaria commends the announcement by Minister Svenja Schulze on the occasion of World Tuberculosis Day to make available an additional EUR175 million to the Global Fund’s COVID-19 Response Mechanism, p…
22 March 2022
Global Fund Calls for Renewed Urgency in Fight to End TB
On World TB Day, 24 March, the Global Fund is urgently calling for the world to reignite the fight to end tuberculosis (TB) by 2030.
Global Research Collaboration for Infectious Disease Preparedness [GloPID-R] [to 26 Mar 2022]
News
23/03/2022
Researchers and funders around the world rely on the COVID-19 Research Project Tracker and associated Living Mapping Review (LMR) to funnel resources where needs are greatest by tracking the latest COVID-19 research trends and gaps. For the first time, the LMR features an analysis of research projects on our Tracker mapped against the pillars and priorities outlined in the UN Research Roadmap for the COVID-19 Recovery…
07/03/2022
The second webinar in the ZonMw series ‘Response to COVID-19 vaccine in patients with a hematological condition and primary immunodeficiencies’… Monday April 4, 2022, from 5pm to 6pm CET.
Hilleman Laboratories [to 26 Mar 2022]
News & Insights
No new digest content identified
HHMI – Howard Hughes Medical Institute [to 26 Mar 2022]
Press Room
No new digest content identified
Human Vaccines Project [to 26 Mar 2022]
http://www.humanvaccinesproject.org/
News
No new digest content identified
IAVI [to 26 Mar 2022]
No new digest content identified
ICRC [to 26 Mar 2022]
https://www.icrc.org/en/whats-new
What’s New
Thank you to the Ambassador of Mexico for organising this meeting and thank you for the opportunity to join all of you today.Just yesterday the Security Council met to discuss Syria which has now entered its 11th year of conflict.
25-03-2022 | Statement
ICRC President completes visit to Russia to speak about humanitarian issues in armed conflict
Peter Maurer, the president of the International Committee of the Red Cross (ICRC), has completed a two-day visit to Moscow where he continued ongoing humanitarian discussions with the Russian authorities.
24-03-2022 | News release
Having access to water is increasingly a matter of survival in conflict zones
Vice-President of the ICRC Gilles Carbonnier addresses the issues of water access and the impact of conflicts and climate change at the ninth World Water Forum in Dakar.
21-03-2022 | News release
International Coalition of Medicines Regulatory Authorities [ICMRA]
http://www.icmra.info/drupal/en/news
Selected Statements, Press Releases, Research
No new digest content identified.
IFFIm
Press Releases/Announcements
No new digest content identified.
IFRC [to 26 Mar 2022]
http://media.ifrc.org/ifrc/news/press-releases/
Afghanistan: Food shortages escalate as spring fields remain bare
“In Ukraine, the needs are growing every day,” says Red Cross President
Institut Pasteur [to 26 Mar 2022]
https://www.pasteur.fr/en/press-area
No new digest content identified.
IOM / International Organization for Migration [to 26 Mar 2022]
http://www.iom.int/press-room/press-releases
News – Selected
23 Mar 2022
IOM Launches Cash Assistance Programme in Ukraine
22 Mar 2022
IOM, UNHCR Welcome the First Flights of Refugees Out of Moldova to EU Member States
21 Mar 2022
Almost 6.5 Million People Internally Displaced in Ukraine: IOM
ISC / International Science Council [to 26 Mar 2022]
https://council.science/current/
ISC is a non-governmental organization with a unique global membership that brings together 40 international scientific Unions and Associations and over 140 national and regional scientific organizations including Academies and Research Councils.
Combating predatory journals and conferences through systemic change in scientific publishing
So-called ‘predatory’ activities in academic publishing and conferences are on the increase worldwide and ‘risk becoming engrained in research culture’, according to a new InterAcademy Partnership report, which draws on a global survey of researchers.
IVAC [to 26 Mar 2022]
No new digest content identified.
IVI [to 26 Mar 2022]
March 24, 2022
Johns Hopkins Center for Health Security [to 26 Mar 2022]
https://www.centerforhealthsecurity.org/news/center-news/
Center News
No new digest content identified.
MSF/Médecins Sans Frontières [to 26 Mar 2022]
Latest [Selected Announcements]
Bangladesh
Unprecedented increase of scabies cases in Cox’s Bazar refugee camps
Project Update 25 Mar 2022
Tajikistan
Helping kids to beat TB in Tajikistan
Project Update 23 Mar 2022
National Academy of Medicine – USA [to 26 Mar 2022]
News
No new digest content identified.
National Academy of Sciences – USA [to 26 Mar 2022]
http://www.nasonline.org/news-and-multimedia/
News
Designing COVID-19 Vaccine Requirements and Incentive Programs ‘ New Expert Consultation
March 23, 2022
Vaccination mandates and requirements can be effective in increasing COVID-19 vaccination rates but their success depends on being targeted and on building trust says a new rapid expert consultation which also outlines considerations for using incentives to promote booster uptake.
National Vaccine Program Office – U.S. HHS [to 26 Mar 2022]
https://www.hhs.gov/vaccines/about/index.html
Upcoming Meetings/Latest Updates
Vaccines Federal Implementation Plan 2021-2025
On Wednesday March 2, 2022, the U.S. Department of Health and Human Services (HHS) published a Request for Information (RFI) to solicit stakeholder written public comments on the draft Vaccines Federal Implementation Plan 2021-2025- PDF*. HHS values input from all stakeholders and will take all public comments into consideration before finalizing this document.
We encourage your input or comments and ask that you circulate this information to others who may also wish to provide comments. Information about how to provide written public comment is found on HHS.gov and the deadline for submissions is 5 p.m. EST Tuesday March 29, 2022.
The Vaccines Federal Implementation Plan is a companion document to the Vaccines National Strategic Plan 2021-2025 published in January 2021. This plan outlines the federal government’s broad national vaccination goals and offers a framework to eliminate vaccine-preventable diseases through safe and effective vaccination over the lifespan, for both federal agencies and external partners.
The implementation plan focuses on the specific actions that federal agencies can take to further those same national vaccination goals.
http://www.nih.gov/news-events/news-releases
No new digest content identified.
OECD [to 26 Mar 2022]
http://www.oecd.org/newsroom/publicationsdocuments/bydate/
Newsroom/Library
Shortages of medicines in OECD countries
Working Paper, English, 24 Mar 2022, 54 Pages:
Suzannah Chapman, Guillaume Dedet, Ruth Lopert
Even in wealthy economies, access to medicines is increasingly affected by medicine shortages – an issue exacerbated with the onset of the COVID-19 pandemic. The aim of this paper was to examine the extent and nature of medicine shortages in OECD countries (pre-COVID-19) and explore the reasons for this growing global problem. Although differences in monitoring mechanisms make multi-country analyses challenging, a sample of 14 OECD countries reported a 60% increase in the number of shortage notifications over the period 2017-2019. While the complexity of pharmaceutical manufacturing and supply chains hampers root cause analyses, available literature suggests that shortages, as reported by marketing authorisation holders, are predominantly due to manufacturing and quality issues. Nevertheless, commercial factors – and the policy settings that influence them – may play an important role. Although several OECD countries have implemented policy measures to mitigate, monitor and prevent shortages, more robust data and further analyses of root causes and effective policy responses are needed. The way forward should involve a global approach that engages all relevant actors and looks beyond the health care sector alone.
PATH [to 26 Mar 2022]
https://www.path.org/media-center/
Press Releases
PATH and the Foreign, Commonwealth & Development Office supported the Vietnam Ministry of Health in developing Vietnam’s COVID-19 digital vaccination certificate
March 22, 2022 by PATH
The Vietnam Ministry of Health, the UK Foreign, Commonwealth & Development Office, and PATH came together for the dissemination workshop of a project to internationalize Vietnam’s COVID-19 vaccine data and certificates.
Hanoi, Vietnam, March 22, 2022—The Vietnam Ministry of Health (MOH), the UK Foreign, Commonwealth & Development Office (FCDO), PATH, and implementing partners hosted the dissemination workshop for a six-month collaboration to support the development of Vietnam’s COVID-19 digital vaccination certification. The workshop was attended by the Deputy Minister of the Vietnam MOH, Tran Van Thuan; the British Ambassador to Vietnam, Gareth Ward; and representatives of implementing partners.
The project is funded by the Vaccine Data Co-Lab, a component of the Frontier Technology program and an FCDO-led collaboration supporting actionable solutions that improve data-driven prioritization, allocation, and distribution of COVID-19 vaccines. In May 2021, the UK-funded program launched an open call for technical proposals to identify organizations working directly with local and national governments in low- and middle-income countries to ensure sustained capacity for vaccine deployment. PATH was the first organization to receive a grant from the Vaccine Data Co-Lab…
Sabin Vaccine Institute [to 26 Mar 2022]
http://www.sabin.org/updates/pressreleases
Statements and Press Releases
No new digest content identified.
UNAIDS [to 26 Mar 2022]
Selected Press Releases/Reports/Statements
24 March 2022
Working together to help refugees in the Republic of Moldova
23 March 2022
23 March 2022
21 March 2022
Eastern Cape becomes the first South Africa province to campaign on U = U
UNHCR Office of the United Nations High Commissioner for Refugees [to 26 Mar 2022]
http://www.unhcr.org/en-us/media-centre.htmlS
Selected News Releases, Announcements
UNHCR lauds Philippines’ accession to 1961 statelessness convention
Number of displaced Nicaraguans in Costa Rica doubles in less than a year
A month since the start of the war, almost a quarter of Ukraine’s population are displaced
Statement by UN High Commissioner for Refugees Filippo Grandi
One year after Palma attacks, thousands continue to flee violence in northern Mozambique
UNHCR and partners rush aid to thousands in Mozambique after Tropical Cyclone Gombe
IOM, UNHCR welcome the first flights of refugees out of Moldova to EU Member States
UNHCR condemns deadly attack on displaced people in DR Congo
High Commissioner’s message on the International Day for the Elimination of Racial Discrimination
Statement by Filippo Grandi, UN High Commissioner for Refugees
21 March 2022
https://www.unicef.org/media/press-releases
Press Releases, News Notes, Statements [Selected]
More than half of Ukraine’s children displaced after one month of war
https://www.unicef.org/press-releases/more-half-ukraines-children-displaced-after-one-month-war
Girls in Afghanistan must go back to school without any further delays
UNICEF signs supply agreement with Pfizer for oral COVID-19 treatment
https://www.unicef.org/press-releases/unicef-signs-supply-agreement-pfizer-oral-covid-19-treatment
[See COVID above for detail]
UNICEF Executive Director Catherine Russell’s humanitarian briefing at the World Economic Forum
Polio immunisation campaign begins in four countries after case confirmed in Malawi – UNICEF
https://www.unicef.org/press-releases/polio-immunisation-ESAR
Featured News
24 March 2022
[See COVID above for detail]
23 March 2022
Geneva – In advance of World TB Day, 24 March, Unitaid reaffirms its commitment to bring innovative approaches to the fight against TB.
The COVID-19 pandemic has had a devastating effect on health programmes worldwide, but tuberculosis (TB) efforts have been disproportionately affected. Disruptions and delays to crucial services caused deaths from TB to increase for the first time in over a decade.
“In a rapidly changing world, the need to confront new challenges with updated tools and strategies is more salient than ever,” said Dr Philippe Duneton, Executive Director of Unitaid. “The tuberculosis bacteria was identified 140 years ago. Yet it continues to cause 1.5 million deaths each year, and millions of people around the world still lack access to the best tools, treatments, and prevention.
“The COVID-19 pandemic puts this in a particularly stark light. Since it began just over two years ago, we have developed and deployed rapid at-home tests, several powerful vaccines, multiple treatments that avert severe disease and mobilized billions in financing. And though there remains much to do, we are hopeful that we’re starting to turn a corner…
Vaccine Equity Cooperative [nee Initiative] [to 26 Mar 2022]
News
No new digest content identified.
Vaccination Acceptance & Demand Initiative [Sabin) [to 26 Mar 2022]
https://www.vaccineacceptance.org/
Announcements, Blog
No new digest content identified.
Vaccine Confidence Project [to 26 Mar 2022]
http://www.vaccineconfidence.org/
News, Research and Reports
No new digest content identified.
Vaccine Education Center – Children’s Hospital of Philadelphia [to 26 Mar 2022]
http://www.chop.edu/centers-programs/vaccine-education-center
Vaccine Update for Providers , March 2022
In this issue:
Wellcome Trust [to 26 Mar 2022]
News. Opinion, Reports
Explainer
Explained: How climate affects health
20 March 2022
Climate change is a global health problem already impacting millions of people around the world. Here’s what you need to know.
The Wistar Institute [to 26 Mar 2022]
https://www.wistar.org/news/press-releases
No new digest content identified.
WFPHA: World Federation of Public Health Associations [to 26 Mar 2022]
Latest News – Blog
No new digest content identified.
World Bank [to 26 Mar 2022]
http://www.worldbank.org/en/news/all
More than 120,000 Jordanian households to benefit from additional financing Washington DC, March 22, 2022 – The World Bank has approved US$350 million in additional financing for Jordan’s COVID-19…
Date: March 22, 2022 Type: Press Release
World Customs Organization – WCO [to 26 Mar 2022]
Latest News
Customs controls for COVID-19-related goods discussed with ASEAN Ambassadors
25 March 2022
WCO and INCB unite to support access to controlled medicines in Ukraine and neighbouring countries
22 March 2022
World Organisation for Animal Health (OIE) [to 26 Mar 2022]
https://www.oie.int/en/media/news/
Press Releases, Statements
UN Environment Programme joins alliance to implement One Health approach
18 March 2022
Joint FAO/OIE/WHO/UNEP Press release
Strengthened partnership aims to accelerate coordinated strategy on human, animal and ecosystem health
Rome/Paris/Geneva/Nairobi – Work to tackle the challenges of human, animal and ecosystem health using a more integrated approach has seen significant progress in the past year, leaders of three international organizations cooperating across these sectors said, as they expanded their group to include a fourth body, the UN Environment Programme (UNEP).
At its annual executive meeting this week, the Tripartite partnership for One Health, bringing together the Food and Agriculture Organization of the United Nations (FAO), the World Health Organization (WHO) and the World Organisation for Animal Health (OIE), formally became the Quadripartite as it signed a Memorandum of Understanding with UNEP.
The One Health approach aims to sustainably balance and optimize the health of people, animals, ecosystems and the wider environment. It mobilizes multiple sectors, disciplines and communities to work together to foster well-being and tackle threats to health and ecosystems. And it addresses the collective need for clean water, energy and air, safe and nutritious food, action on climate change, and contributing to sustainable development…
::::::
ARM [Alliance for Regenerative Medicine] [to 26 Mar 2022]
Selected Press Releases
No new digest content identified.
BIO [to 26 Mar 2022]
https://www.bio.org/press-releases
Press Releases, Letters, Testimony, Comments [Selected]
New Season of Biotech Podcast Builds Trust in Science
March 22, 2022
DCVMN – Developing Country Vaccine Manufacturers Network [to 26 Mar 2022]
No new digest content identified.
ICBA – International Council of Biotechnology Associations [to 26 Mar 2022]
https://internationalbiotech.org/news/
News
No new digest content identified.
http://www.ifpma.org/resources/news-releases/
Selected Press Releases, Statements, Publications
Joint Industry Statement on the War in Ukraine
21 March 2022 – The global research-based pharmaceutical industry stands in solidarity with the people of Ukraine and condemns the invasion of their country and the suffering it continues to cause. Overcoming the challenges that this unprecedented humanitarian crisis poses for patients is our main concern.
We are united in our mission of providing treatments and vaccines to all those affected by the war, wherever they are. Safe passage of medical products remains a top priority.
The industry is working in a variety of ways to support those affected by the unfolding humanitarian crisis. This includes providing free essential medicines and giving financial support to NGOs on the ground. We are monitoring for supply chain disruptions and building supply capacity where it’s needed as well as working with the wider health community to address issues as they arise.
To learn more about individual company efforts, please visit the website set up by the European Federation of Pharmaceutical Industries and Associations’ (EFPIA), found here.
International Generic and Biosimilar Medicines Association [IGBA]
https://www.igbamedicines.org/
News
No new digest content identified.
International Alliance of Patients’ Organizations – IAPO [to 26 Mar 2022]
https://www.iapo.org.uk/news/topic/6
Press and media [Selected]
No new digest content identified.
PhRMA [to 26 Mar 2022]
Latest News [Selected]
No new digest content identified.
Journal Watch
Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org
Tactical Health and Law Enforcement
AMA Journal of Ethics
Volume 24, Number 2: E107-163 Feb 2022
https://journalofethics.ama-assn.org/issue/tactical-health-and-law-enforcement
Tactical Health and Law Enforcement
Tactical health involves providing field-based clinical support to law enforcement operations during frontline crisis interventions and prehospital emergency care. Health professional skill can inform individual officers’ occupational health maintenance and help agents of the state navigate primary and secondary trauma and posttrauma experiences in field- and clinic-based settings. Tactical health expertise can also inform department- and agency-level policies, decisions, and responses to community health and safety threats. Ethical questions considered in this issue focus on the nature and scope of health professionals’ collaborations with law enforcement personnel during and following critical event preparation and responses.
Disease transmission and mass gatherings: a case study on meningococcal infection during Hajj
BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 26 Mar 2022)
Disease transmission and mass gatherings: a case study on meningococcal infection during Hajj
Mass gatherings can not only trigger major outbreaks on-site but also facilitate global spread of infectious pathogens. Hajj is one of the largest mass gathering events worldwide where over two million pilgrim…
Authors: Laurent Coudeville, Amine Amiche, Ashrafur Rahman, Julien Arino, Biao Tang, Ombeline Jollivet, Alp Dogu, Edward Thommes and Jianhong Wu
Citation: BMC Infectious Diseases 2022 22:275
Content type: Research article Published on: 22 March 2022
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2
BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 26 Mar 2022)
Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2
From January to May 2021 the alpha variant (B.1.1.7) of SARS-CoV-2 was the most commonly detected variant in the UK. Following this, the Delta variant (B.1.617.2) then became the predominant variant. The UK CO…
Authors: Karan Pattni, Daniel Hungerford, Sarah Adams, Iain Buchan, Christopher P. Cheyne, Marta García-Fiñana, Ian Hall, David M. Hughes, Christopher E. Overton, Xingna Zhang and Kieran J. Sharkey
Citation: BMC Infectious Diseases 2022 22:270
Content type: Research article Published on: 20 March 2022
Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives
BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 26 Mar 2022)
Ethical and regulatory implications of the COVID-19 pandemic for the medical devices industry and its representatives
The development and deployment of medical devices, along with most areas of healthcare, has been significantly impacted by the COVID-19 pandemic. This has had variable ethical implications, two of which we wil…
Authors: Brette Blakely, Wendy Rogers, Jane Johnson, Quinn Grundy, Katrina Hutchison, Robyn Clay-Williams, Bernadette Richards and Guy Maddern
Citation: BMC Medical Ethics 2022 23:31
Content type: Debate Published on: 23 March 2022
Indicators and criteria of consciousness: ethical implications for the care of behaviourally unresponsive patients
BMC Medical Ethics
http://www.biomedcentral.com/bmcmedethics/content
(Accessed 26 Mar 2022)
Indicators and criteria of consciousness: ethical implications for the care of behaviourally unresponsive patients
Assessing consciousness in other subjects, particularly in non-verbal and behaviourally disabled subjects (e.g., patients with disorders of consciousness), is notoriously challenging but increasingly urgent. T…
Authors: Michele Farisco, Cyriel Pennartz, Jitka Annen, Benedetta Cecconi and Kathinka Evers
Citation: BMC Medical Ethics 2022 23:30
Content type: Debate Published on: 21 March 2022
Cross-country evidence on the role of national governance in boosting COVID-19 vaccination
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 26 Mar 2022)
Cross-country evidence on the role of national governance in boosting COVID-19 vaccination
Frequent mutations of the COVID-19 virus, such as the Delta and Omicron variants, have prolonged the pandemic. Rich countries have approved the booster shots (3rd doses) of vaccine, but this causes further delay …
Authors: Takeshi Aida and Masahiro Shoji
Citation: BMC Public Health 2022 22:576
Content type: Research Published on: 23 March 2022
Willingness and uptake of the COVID-19 testing and vaccination in urban China during the low-risk period: a cross-sectional study
BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 26 Mar 2022)
Willingness and uptake of the COVID-19 testing and vaccination in urban China during the low-risk period: a cross-sectional study
Regular testing and vaccination are effective measures to mitigate the ongoing COVID-19 pandemic. Evidence on the willingness and uptake of the COVID-19 testing is scarce, and the willingness and uptake of vac…
Authors: Suhang Song, Shujie Zang, Liubing Gong, Cuilin Xu, Leesa Lin, Mark R. Francis and Zhiyuan Hou
Citation: BMC Public Health 2022 22:556
Content type: Research Published on: 21 March 2022
Advocating for evidence-informed decisions to make healthcare fit for each person
BMJ Evidence-Based Medicine
April 2022 – Volume 27 – 2
https://ebm.bmj.com/content/27/2
Editorial
Advocating for evidence-informed decisions to make healthcare fit for each person (10 March, 2022)
Juan Victor Ariel Franco, Kerry Dwan, Luis Ignacio Garegnani, Marleen Kunneman, Eva Madrid, Maria-Inti Metzendorf, Nicolás Meza, David Nunan, Georgia C Richards, Paula Riganti, Areti Angeliki Veroniki
Age-based exclusions in clinical trials: A review and new perspectives
Contemporary Clinical Trials
Volume 114 March 2022
https://www.sciencedirect.com/journal/contemporary-clinical-trials/vol/114/suppl/C
Research article Abstract only
Age-based exclusions in clinical trials: A review and new perspectives
Diep Nguyen, Grace Mika, Anh Ninh
Article 106683
Tools for assessing the scalability of innovations in health: a systematic review
Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 26 Mar 2022]
Tools for assessing the scalability of innovations in health: a systematic review
The last decade has seen growing interest in scaling up of innovations to strengthen healthcare systems. However, the lack of appropriate methods for determining their potential for scale-up is an unfortunate …
Authors: Ali Ben Charif, Hervé Tchala Vignon Zomahoun, Amédé Gogovor, Mamane Abdoulaye Samri, José Massougbodji, Luke Wolfenden, Jenny Ploeg, Merrick Zwarenstein, Andrew J. Milat, Nathalie Rheault, Youssoufa M. Ousseine, Jennifer Salerno, Maureen Markle-Reid and France Légaré
Citation: Health Research Policy and Systems 2022 20:34
Content type: Review Published on: 24 March 2022
Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report
Health Research Policy and Systems
http://www.health-policy-systems.com/content
[Accessed 26 Mar 2022]
Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report
The COVID-19 pandemic has led to an increased interest in communication with the public regarding vaccination. Our recent Cochrane qualitative evidence synthesis points to several factors that could influence …
Authors: Claire Glenton, Benedicte Carlsen, Brita Askeland Winje, Renske Eilers, Manuela Dominique Wennekes, Tammy C. Hoffmann and Simon Lewin
Citation: Health Research Policy and Systems 2022 20:31
Content type: Research Published on: 19 March 2022
Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore
JAMA
March 22/29, 2022, Vol 327, No. 12, Pages 1109-1194
https://jamanetwork.com/journals/jama/currentissue
Research Letter
Association of Homologous and Heterologous Vaccine Boosters With COVID-19 Incidence and Severity in Singapore
Sharon Hui Xuan Tan, MPH; Rachael Pung, MSc; Lin-Fa Wang, PhD; et al.
free access has active quiz
JAMA. 2022;327(12):1181-1182. doi:10.1001/jama.2022.1922
This study estimates SARS-CoV-2 infections and disease severity with the receipt of a booster and by type of booster.
COVID-19 Update March 26, 2022
JAMA Network
COVID-19 Update March 26, 2022
These articles on COVID-19 were published across the JAMA Network in the last week.
Use of Community Listening Sessions to Disseminate Research Findings to Past Participants and Communities
Journal of Community Health
Volume 47, issue 2, April 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-2
Original Paper
Use of Community Listening Sessions to Disseminate Research Findings to Past Participants and Communities
Authors (first, second and last of 8)
Jennifer Cunningham-Erves
Elizabeth C. Stewart
Stephania T. Miller
Published: 08 October 2021
Pages: 201 – 210
Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study
Journal of Community Health
Volume 47, issue 2, April 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-2
Active Surveillance of Adverse Events in Healthcare Workers Recipients After Vaccination with COVID-19 BNT162b2 Vaccine (Pfizer-BioNTech, Comirnaty): A Cross-Sectional Study
Authors (first, second and last of 12)
Giancarlo Ripabelli
Manuela Tamburro
Michela Lucia Sammarco
Content type: Original Paper
Published: 09 October 2021
Pages: 211 – 225
Influenza Vaccination During COVID-19 in a Rural Community: A Cross-sectional Survey
Journal of Community Health
Volume 47, issue 2, April 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-2
Influenza Vaccination During COVID-19 in a Rural Community: A Cross-sectional Survey
Authors
Rebecca E. Marcus
Victor O. Kolade
Content type: Original Paper
Published: 13 October 2021
Pages: 226 – 231
Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine
Journal of Community Health
Volume 47, issue 2, April 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-2
Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine
Authors (first, second and last of 9)
Ramey Moore
Rachel S. Purvis
Pearl A. McElfish
Content type: Original Paper
Published: 23 October 2021
Pages: 237 – 245
COVID-19 Vaccine Uptake Among College Students at a Midwest University
Journal of Community Health
Volume 47, issue 2, April 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-2
COVID-19 Vaccine Uptake Among College Students at a Midwest University
Authors (first, second and last of 8)
Amy J. Wotring
Matthew Hutchins
Linda Behrendt
Content type: Original Paper
Published: 20 November 2021
Pages: 292 – 297
Using social media listening and data mining to understand travellers’ perspectives on travel disease risks and vaccine-related attitudes and behaviours
Journal of Travel Medicine
Volume 29, Issue 2, March 2022
https://academic.oup.com/jtm/issue
Original Articles
Using social media listening and data mining to understand travellers’ perspectives on travel disease risks and vaccine-related attitudes and behaviours
Catherine Bravo, PhD, Valérie Bosch Castells, MSc, Susann Zietek-Gutsch, MBA, Pierre-Antoine Bodin, MSc, Cliona Molony, PhD …
Evaluating COVID-19 vaccines in the real world
The Lancet
Mar 26, 2022 Volume 399 Number 10331 p1201-1278, e17-e19
https://www.thelancet.com/journals/lancet/issue/current
Comment
Evaluating COVID-19 vaccines in the real world
Edward J Mills, Gilmar Reis
Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial
The Lancet
Mar 26, 2022 Volume 399 Number 10331 p1201-1278, e17-e19
https://www.thelancet.com/journals/lancet/issue/current
Articles
Effectiveness and cost-effectiveness against malaria of three types of dual-active-ingredient long-lasting insecticidal nets (LLINs) compared with pyrethroid-only LLINs in Tanzania: a four-arm, cluster-randomised trial
Jacklin F Mosha, et al.
Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study
The Lancet
Mar 26, 2022 Volume 399 Number 10331 p1201-1278, e17-e19
https://www.thelancet.com/journals/lancet/issue/current
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries
The Lancet
Mar 26, 2022 Volume 399 Number 10331 p1201-1278, e17-e19
https://www.thelancet.com/journals/lancet/issue/current
Health Policy
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries
NCD Countdown 2030 collaborators
Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt
Maternal and Child Health Journal
Volume 26, issue 3, March 2022
https://link.springer.com/journal/10995/volumes-and-issues/26-3
Original Paper
Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt
Authors (first, second and last of 4)
Mariam Lotfy Mohamed, Ayat Mahmoud Tawfik, Sally Fawzy Elotla
Published: 21 January 2022
Pages: 565 – 574
The alarming rise of complex genetic testing in human embryo selection
Nature
Volume 603 Issue 7902, 24 March 2022
https://www.nature.com/nature/volumes/603/issues/7901
Editorial | 21 March 2022
The alarming rise of complex genetic testing in human embryo selection
Companies are marketing polygenic risk scores as part of IVF well ahead of a full understanding of the potential benefits — or dangers.
